GTC
CAPR icon

Ghost Tree Capital’s Capricor Therapeutics CAPR Stock Holding History

Ghost Tree Capital’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.9M Buy
+125,000
New +$618K 0.57% 45

Other funds holding CAPR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Superstring Capital Management New York $140M AUM 323.19% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Ghost Tree Capital's CAPR Position: Q3 2024 in Review

Ghost Tree Capital opened a new position in Capricor Therapeutics (CAPR) in Q3 2024: 125,000 shares worth $1.9M. The stake represents 0.57% of the portfolio and ranks #45 among its holdings.

75 funds tracked by Wall St. Rank hold CAPR as of Q3 2024.

  • Ghost Tree Capital held 125,000 shares of Capricor Therapeutics worth $1.9M as of Q3 2024.
  • Capricor Therapeutics was a new Ghost Tree Capital position in Q3 2024.
  • Capricor Therapeutics made up 0.57% of Ghost Tree Capital's portfolio in Q3 2024, its #45 holding.
  • 75 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q3 2024.

Based on Ghost Tree Capital's 13F filing for Q3 2024, filed 14 Nov 2024.